- Report
- September 2022
- 176 Pages
Global
From €2261EUR$2,500USD£1,952GBP
- Drug Pipelines
- July 2022
- 71 Pages
Global
From €9038EUR$9,995USD£7,805GBP
- Report
- June 2022
- 68 Pages
Global
From €3160EUR$3,495USD£2,729GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Drug Pipelines
- April 2022
- 92 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Clinical Trials
- February 2022
- 461 Pages
Global
From €2261EUR$2,500USD£1,952GBP
- Clinical Trials
- January 2022
- 419 Pages
Global
From €2261EUR$2,500USD£1,952GBP
- Report
- December 2021
- 134 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Report
- November 2021
- 124 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Report
- November 2021
- 131 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Report
- August 2021
- 52 Pages
Global
From €3613EUR$3,995USD£3,119GBP
- Report
- November 2020
- 46 Pages
Global
From €3613EUR$3,995USD£3,119GBP
- Report
- May 2020
- 218 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Report
- May 2020
- 35 Pages
Global
From €3613EUR$3,995USD£3,119GBP
- Report
- May 2020
- 47 Pages
Global
From €3613EUR$3,995USD£3,119GBP
- Report
- February 2020
- 163 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Report
- February 2020
- 44 Pages
Asia Pacific
From €3160EUR$3,495USD£2,729GBP
- Report
- February 2020
- 160 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Report
- December 2019
- 190 Pages
Global
From €13559EUR$14,995USD£11,709GBP
- Report
- December 2019
- 63 Pages
Global
From €3613EUR$3,995USD£3,119GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more